14.84SEK-2.50%Mkt Cap: 2.05B SEKP/E: 8.94Last update: 2026-06-01
Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, D…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap2.05B SEK
Enterprise Value1.60B SEK
Revenue (TTM)429.29M SEK
Gross Profit428.97M SEK
Net Income (TTM)284.67M SEK
Revenue/Share3.157 SEK
Last Price14.84 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees34
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0005794617
Valuation
P/E (Trailing)8.94
P/E (Forward)—
PEG—
EV/EBITDA6.72
EV/Revenue3.72
P/S4.89
P/B3.31
EPS (TTM)1.66
EPS (Forward)—
52W Range
7.91034% of range28.30
52W High28.30 SEK
52W Low7.910 SEK
Profitability
Gross Margin98.75%
Oper. Margin-1185.04%
EBITDA Margin55.39%
Profit Margin65.53%
ROE44.82%
ROA41.88%
Growth
Revenue Growth-52.20%
Earnings Growth—
Cash Flow & Leverage
Operating CF273.86M SEK
CapEx (TTM)73.56M SEK
FCF Margin19.56%
FCF Yield4.10%
Net Debt-531.98M SEK
Net Debt/EBITDA-2.24
Balance Sheet
Debt/Equity0.00
Current Ratio10.55
Quick Ratio10.27
Book Value/Sh4.602 SEK
Cash/Share3.803 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating0.0 (Hold)
Target (Mean)20.00 SEK
Target Range20.00 SEK – 20.00 SEK
# Analysts1
Ownership
Shares Out.138.03M
Float125.17M
Insiders18.41%
Institutions14.95%
Technical
SMA 5014.74 (+0.7%)
SMA 20016.99 (-12.7%)
Beta—
S&P 52W Chg27.70%
Avg Vol (30d)509.26K
Avg Vol (10d)679.48K
Technical Indicators
RSI (14)61.3
MACD-0.1052
MACD Signal-0.3948
MACD Hist.+0.2896
BB Upper15.05 SEK
BB Middle13.87 SEK
BB Lower12.70 SEK
BB Width16.98%
ATR (14)0.8286 SEK
Vol Ratio (20d)1.67x